Hand microbial eczemas

Cover Page

Abstract


The article concerns with the case dermatitis of hands. It analyses the modern classifications of hand dermatitis, epidemiological aspects, initiating agents, clinical treatment and therapeutical principals. The special focus is put on microbal eczemas and chronical allergodermathosis of hands. Among the pathogenetical factors of development and maintaining of dermatological inflammation the problem of microbacterial infection of skin is emphasized. The effectiveness and safety of external therapy of patients with microbal and chronical hand eczemas is proven and established while using the multicomponental medication Triderm.

About the authors

O. B. Tamrazova

People's Friendship University of Russia

Author for correspondence.
Email: anait_tamrazova@mail.ru

Russian Federation

M. V. Novoseltsev

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of Department of Health protection of Moscow

Email: noemail@neicon.ru

Russian Federation

References

  1. Samtsov A.V., Barbinov V.V. Dermatovenerologiya. Uchebnik dlya meditsinskih vuzov. SPb: SpetsLit 2008: 302. [Самцов А.В., Барбинов В.В. Дерматовенерология. Учебник для медицинских вузов. СПб: СпецЛит 2008: 302.]
  2. Veien N.K., Menné T. Treatment of Hand Eczema. Skin Therapy Lett 2003; 8 (5): 4-7.
  3. Molin S., Diepgen T.L., Ruzicka T., Prinz J.C. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol 2011 Aug; 36 (6): 595-601.
  4. Berth-Jones J. Hand eczema. In: Burns T. et al., editors. Rook’s textbook of dermatology. 8th ed. Oxford: Wiley-Blackwell 2010: 23.13-23.
  5. Meding B., Jarvholm B. Incidence of hand eczema-a population-based retrospective study. J Invest Dermatol 2004; 122 (4): 873-877.
  6. Susitaival Р., Flyvholm М.А., Meding B., Kanerva L., lindberg M., Svensson A., Olafsson J.H. Nordic Occupational Skin Questionnaire (N0SQ-2002): a new tool for surveying occupational skin diseases and exposure. Contact Dermatitis 2003; 49: 70-766.
  7. Bryld L.E., Hindsberger C., Kyvik K.O., Agner T., Menne T. Risk factors influencing the development of hand eczema in a population-based twin sample. Br J Dermatol 2003; 149: 1214-1220.
  8. Diepgen Т., Pfarr Е., Zimmermann Т. Efficacy and Tolerability of Alitretinoin for Chronic Hand Eczema Under Daily Practice Conditions: Results of the TOCCATA Open Study Comprising 680 Patients Acta Derm Venereol 2012; 92: 1867-72.
  9. Jungbauer F.H., van der Vleuten P., Grotoff J.V., Coenraads J.P. Irritant hand dermatitis: severity of disease, occupational exposure to skin irritants and preventive measures 5 years after initial diagnosis. Contact Dermatitis 2004; 50: 245-51.
  10. Meding B., Lindahl G., Alderling M., Wrangsjo K., Anveden Berglind I. Is skin exposure to water mainly occupational or non- occupational? A population-based study. Br J Dermatol 2013; 168: 1281-6.
  11. Lin Y.T., Wang C.T., Chiang B.L. Role of bacterial pathogens in atopic dermatitis. Clin Immunol Rev Allergy 2007; 33 (3): 167-77.
  12. Nakamura Y., Oscherwitz J., Nunez G. et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 2013; 503: 397-401.
  13. Cardona I.D., Cho S.H., Leung D.Y. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 2006; 7 (5): 273-9.
  14. Wichmann K., Uter W., Weiss J., Breuer K., Heratizadeh A., Mai U., Werfel T. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009; 161 (2): 300-5.
  15. Pavlov S.T., Shaposhnikov O.K., Samtsov V.I., Ilin I.I. Kozhnyie i venericheskie bolezni. M: Meditsina 1975; 392. [Павлов С.Т., Шапошников O.K., Самцов В.И., Ильин И.И. Кожные и венерические болезни. М: Медицина 1975; 392.]
  16. Fayzullin E.V., Fazyilov V.H., Zinatulina G.M. Mikrobnaya ekzema. Kazan med zhurn 2009; 90 (3): 454-457. [Файзуллин Е.В., Фазылов В.Х., Зинатулина Г.М. Микробная экзема. Казан мед журн 2009; 90 (3): 454-457.]
  17. Perlamutrov Yu.N., Olhovskaya K.B. Prakticheskie aspektyi vedeniya bolnyih s hronicheskoy ekzemoy kistey. Vestn dermatol venerol 2013; 6: 90-93. [Перламутров Ю.Н., Ольховская К.Б. Практические аспекты ведения больных с хронической экземой кистей. Вестн дерматол венерол 2013; (6): 90-93. ]
  18. Matushevskaya E.V., Masyukova S.A., Skripkina P.A., Chistyakova T.V. Topicheskie kombinirovannyie kortikosteroidnyie preparatyi v lechenii atopicheskogo dermatita. Sovr probl dermatovenerol, immunol i vracheb kosmetol 2009; 2: 14-19. [Матушевская Е.В., Масюкова С.А., Скрипкина П.А., Чистякова Т.В. Топические комбинированные кортикостероидные препараты в лечении атопического дерматита. Совр пробл дерматовенерол, иммунол и врачеб косметол 2009; (2): 14-19.]
  19. Pankratov V.G., Poplavskaya N.B., Rimko E.G., Dzhoshkun Sadeddin, Suhobokova N.N. Opyit ispolzovaniya krema Triderm v dermatologicheskoy praktike. Retsept 2012; 3 (83): 130-37. [Панкратов В.Г., Поплавская Н.Б., Римко Е.Г., Джошкун Садеддин, Сухобокова Н.Н. Опыт использования крема Тридерм в дерматологической практике. Рецепт 2012; 3 (83): 130-37.]
  20. Kadyigrob I.V., Serbin I.V., Gutsu N.V. Klinicheskiy opyit lecheniya atopicheskogo dermatita, oslozhnennogo piodermiey. UkraInskiy zhurnal dermatologII, venerologII, kosmetologII 2015; 1 (56): 81-87. [Кадыгроб И.В., Сербин И.В., Гуцу Н.В. Клинический опыт лечения атопического дерматита, осложненного пиодермией. Украінський журнал дерматологіі, венерологіі, косметологіі 2015; 1 (56): 81-87.]
  21. Sergeev Yu.V. Triderm: taktika terapii vospalitelnyih dermatozov, obuslovlennyih gribkovoy i smeshannoy infektsiey. Immunopatologiya, allergologiya, infektologiya 2004; 3: 64-73. [Сергеев Ю.В. Тридерм: тактика терапии воспалительных дерматозов, обусловленных грибковой и смешанной инфекцией. Иммунопатология, аллергология, инфектология 2004; (3): 64-73.]

Statistics

Views

Abstract - 520

PDF (Russian) - 1345

PlumX

Dimensions


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies